White label ELPA - ClinicalTrials.eu

Study on the Risk of Tumor Lysis Syndrome in Adults with Untreated Chronic Lymphocytic Leukemia Using Venetoclax, Obinutuzumab, or Acalabrutinib

Not recruiting

4 1 1 1
Investigated Diseases:
- Chronic lymphocytic leukaemia
Investigated Drugs:
Study on the Safety and Effectiveness of Azacitidine and Venetoclax for Untreated Higher-Risk Myelodysplastic Syndromes Not Eligible for Transplant

Not recruiting

1 1 1
Investigated Drugs:
- Azacitidine
- Venetoclax
Study of Metronomic Oral Vinorelbine with Durvalumab and Tremelimumab for Patients with Advanced Solid Tumors

Not recruiting

3 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- Durvalumab
Study of Inhaled Molgramostim for Adults with Autoimmune Pulmonary Alveolar Proteinosis

Not recruiting

3 1
Investigated Diseases:
- Alveolar proteinosis
Investigated Drugs:
- Molgramostim
+3
Study on Guselkumab for Healing in Crohn’s Disease Patients

Not recruiting

3 1 1
Investigated Drugs:
- Guselkumab
+2
Study on Clebopride for Treating Rumination Syndrome in Patients Suspected of Having the Condition

Not recruiting

3 1 1
Investigated Diseases:
- Merycism
Investigated Drugs:
- Clebopride Hydrogen Maleate
Study of AZD7798 compared to placebo in patients with moderate to severe Crohn’s disease

Not recruiting

2 1
Investigated Drugs:
- Azd7798
+8
Study of ODM-208 (opevesostat) safety and effectiveness in patients with metastatic castration-resistant prostate cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Hormone-refractory prostate cancer
Investigated Drugs:
Study of Pacritinib for Patients with Severe Thrombocytopenia in Myelofibrosis Conditions

Not recruiting

3 1 1 1
Investigated Diseases:
- Myelofibrosis
- Primary myelofibrosis
Investigated Drugs:
+2
Study on Datopotamab Deruxtecan and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer After Osimertinib Treatment

Not recruiting

3 1 1 1
Investigated Drugs:
+1

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies